Stockscreener 앱 받기
49.95
1.36%
-0.69
시간 외 거래:
49.95
전일 마감가:
$50.64
열려 있는:
$50.31
하루 거래량:
574.90K
Relative Volume:
1.16
시가총액:
$2.71B
수익:
$1.24B
순이익/손실:
$23.68M
주가수익비율:
118.93
EPS:
0.42
순현금흐름:
$108.67M
1주 성능:
+3.74%
1개월 성능:
+7.86%
6개월 성능:
+1.11%
1년 성능:
+2.61%
1일 변동 폭
$49.81
$51.08
1주일 범위
$47.90
$52.08
52주 변동 폭
$43.15
$64.47
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
49.95 | 2.71B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
LivaNova (NASDAQ:LIVN) Given "Buy" Rating at Needham & Company LLC - MarketBeat
KBC Group NV Increases Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Heart Valves Tester Market Surging Forward at 8.18% CAGR, Reaching 11.4 Billion USD by 2032 | Jotec GmbH, - EIN News
Getinge exits surgical perfusion, creating opportunity for Livanova - MedTech Dive
Cardiovascular Devices Market Detailed in New Research Report By 2032 | Livanova PLC, B. Braun Melsungen AG - openPR
Defibrillators Market registering a CAGR of 6.6% from 2021 - openPR
Stifel maintains LivaNova stock Buy rating, $72 target By Investing.com - Investing.com Australia
Stifel maintains LivaNova stock Buy rating, $72 target - MSN
Medical Implants Market Projected To Garner Significant Growth by 2024 -2031:Biotronik, Inc, Livanova Plc, - EIN News
(LIVN) On The My Stocks Page - Stock Traders Daily
Artificial Heart Valve Market Trends is Electrifying Growth Cycle: Medtronic, LivaNova, CryoLife - openPR
LivaNova (NASDAQ:LIVN) shareholders have endured a 35% loss from investing in the stock three years ago - Simply Wall St
Should You Sell LivaNova PLC (LIVN)? - Insider Monkey
LivaNova (NASDAQ:LIVN) Downgraded by StockNews.com to Buy - Defense World
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $69.17 - MarketBeat
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - Business Wire
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LivaNova Sets Date for Q4 and Full-Year 2024 Earnings Release and Conference Call - StockTitan
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
JPMorgan Chase & Co. Lowers Stock Position in LivaNova PLC (NASDAQ:LIVN) - Defense World
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Sanctuary Advisors LLC Acquires Shares of 4,268 LivaNova PLC (NASDAQ:LIVN) - Defense World
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Vagus Nerve Stimulators Market Report Analysis and Research - openPR
LivaNova's Depression Treatment Study Shows Promise Despite Mixed Clinical Results - StockTitan
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression - Business Wire
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to "Strong-Buy" - MarketBeat
State Street Corp Cuts Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Fmr LLC Has $1.65 Million Stock Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Captrust Financial Advisors Buys Shares of 4,133 LivaNova PLC (NASDAQ:LIVN) - Defense World
When (LIVN) Moves Investors should Listen - Stock Traders Daily
LivaNova's SWOT analysis: sleep apnea platform could awaken stock potential - Investing.com India
Jane Street Group LLC Sells 19,525 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Barclays PLC - MarketBeat
XTX Topco Ltd Invests $550,000 in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Insider Sell: Francesco Bianchi Sells 1,250 Shares of LivaNova P - GuruFocus.com
Key Factors Shaping the Medical Implants Market: Trends - openPR
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 58,807 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
자본화:
|
볼륨(24시간):